Newstral
Article
Forbes on 2024-03-27 22:58
InnovationRx: Base Editing Pioneer Nicole Gaudelli Joins GV
Related news
- NA step forward in DNA base editing news.harvard.edu
A new tool for editing DNA, one base at a timeLA Times
InnovationRx: #HealthcareIsHard; Plus Waning Covid Vaccine ImmunityForbes
InnovationRx: Digital Health IPO DroughtForbes
InnovationRx: New $217 Million Digital Health FundForbes
InnovationRx: Opioid Overdose Deaths; Plus, ‘Stealth’ OmicronForbes
InnovationRx: Power Women; Plus, Neutralizing OmicronForbes
InnovationRx: Exploring The Future Of Healthcare AIForbes
InnovationRx: FDA Approves Abbott’s Dissolvable StentsForbes
Nicole GelinasNew York Post
InnovationRx: Artificial Intelligence 50; Plus Covid Treatments In IndiaForbes
InnovationRx: Lilly’s Alzheimer’s Drug Candidate Slows Cognitive Decline, Study SuggestsForbes
CRISPR genome-editing pioneer to set up lab at Gladstonebizjournals.com
InnovationRx: Who Do You Trust With Your Health Data?Forbes
InnovationRx: Overdose Death High; Plus $100M For Doctor DataForbes
InnovationRx: AI In Healthcare; Plus, Return Of The Mask?Forbes
InnovationRx: Amwell’s $320 Million Acquisitions; Plus, Will Mask Mandates Help?Forbes
InnovationRx: The Fall Equinox; Plus, U.S. Donates Covid-19 VaccinesForbes
InnovationRx: Monkeypox Vaccine Rollout; Plus, Omicron-Specific BoostersForbes
Editing Kevin DurantThe New Yorker